Thus, as CKD progresses, there is a dysregulation of the FGF23–Klotho axis, meaning that increased FGF23 levels are no longer able to enhance the excretion of phosphorus, leading to hyperphosphatemia, which further stimulates FGF23 secretion from the bone [71]. This evidence concerns the gene FGF23 and hyperphosphatemia.